Generate Biomedicines Inc. (GENB), which recently debuted on the Nasdaq, continues to advance its clinical pipeline across multiple therapeutic areas, modalities, and both wholly owned and partnered programs.
This clinical-stage generative biology company is pioneering the AI revolution in drug design and development. Its clinical-stage programs enabled by its AI Technology Platform include GB-0895, GB-4362, and GB-5267.
For comments and feedback contact: editorial@rttnews.com
May 08, 2026 15:50 ET Manufacturing and services sector survey results and labor market data from main economies were the highlight on the economics news front this week. Factory orders and jobs report dominated the news flow in the U.S. Similarly, industrial production data from German garnered attention in Europe. In Asia, purchasing managers’ survey results from China and the central bank decision from Australia were in focus.